Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVanquis Banking Regulatory News (VANQ)

Share Price Information for Vanquis Banking (VANQ)

Share Price is delayed by 15 minutes
Get Live Data
107.80    0.60 (0.56%)
Bid:
107.60
Ask:
108.20
Spread: 0.60 (0.558%)
Market Cap: £269.86m
VANQ Live PriceLast checked at - London Stock Exchange

Intraday Vanquis Banking Share Chart

Director/PDMR Shareholding

13 Apr 2023 13:00

RNS Number : 1144W
Vanquis Banking Group PLC
13 April 2023
Β 

Vanquis Banking Group plc ("the Company")

Director/PDMR Transaction - Initial Notification

Β 

The Company announces that it has granted the following awards on 12 April 2023 over the Company's ordinary shares of 20 8/11p ("Shares") as follows:

Β 

1. nil-cost options over 406,561 and 298,942 Shares for no consideration to Malcolm Le May and Neeraj Kapur respectively, who are directors/persons discharging managerial responsibility ("PDMRs") in the Company, under the 2020 Restricted Share Plan (the "RSP Options");

Β 

2. market value options linked to the RSP Options over 13,498 and 13,498 Shares for no consideration to Malcolm Le May and Neeraj Kapur respectively, who are directors and PDMRs in the Company, under the 2020 Restricted Share Plan (the "CSOP Options"); and

Β 

3. awards over 190,539 and 125,122 Shares to Malcolm Le May and Neeraj Kapur respectively, who are directors and PDMRs in the Company, under the Deferred Bonus Plan 2022 (the "DBP Awards").

Β 

The RSP Options and CSOP Options work on the basis that the total number of Shares over which the RSP Options and CSOP Options may be exercised cannot exceed that number of Shares as on the grant date had a market value equal to the total number of Shares covered by the RSP Option and CSOP Options less the exercise price payable under the CSOP Options.

Β 

The number of ordinary shares awarded under the RSP Options and DBP Awards is based on the average closing share price on the London Stock Exchange between 31 March 2023 and 6 April 2023 of Β£2.2224, discounted from that price at grant to reflect the absence of dividend equivalents during the vesting period.

Β 

In respect of the DBP Awards, SG Kleinwort Hambros Trust Company (CI) Limited will transfer the beneficial interest to the participants, including the PDMRs, in satisfaction of the DBP Awards granted subject to and in accordance with the terms of the Deferred Bonus Plan 2022.

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Malcolm Le May

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Executive Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Vanquis Banking Group plc

b)

Β 

LEI

Β 

213800U93SZC44VXN635

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Ordinary Shares of 20 8/11p

Β 

GB00B1Z4ST84

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of nil-cost options and a linked share options under the 2020 Restricted Share Plan and an award under the Deferred Bonus Plan 2022.

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0

406,561

Β£2.2224

13,498

Β£1.8440

190,539

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

610,598

Β 

Β£381,351.87

e)

Β 

Date of the transaction

12 April 2023

f)

Β 

Place of the transaction

Outside a trading venue

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Neeraj Kapur

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Vanquis Banking Group plc

b)

Β 

LEI

Β 

213800U93SZC44VXN635

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Β 

Ordinary Shares of 20 8/11p

Β 

GB00B1Z4ST84

Β 

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Acquisition of nil-cost options and a linked share options under the 2020 Restricted Share Plan and an award under the Deferred Bonus Plan 2022.

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£0

298,942

Β£2.2224

13,498

Β£1.8440

125,122

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

437,562

Β 

Β£260,722.92

e)

Β 

Date of the transaction

12 April 2023

f)

Β 

Place of the transaction

Outside a trading venue

Β 

Β 

Name of authorised official of issuer responsible for making notification:

David Whincup, Deputy Company Secretary

Date of Notification:

13 April 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHDXLBFXZLEBBX
Date   Source Headline
10th Jun 20269:53 amRNSHolding(s) in Company
29th May 20264:00 pmRNSTotal Voting Rights
29th May 20269:12 amRNSHolding(s) in Company
28th May 20261:37 pmRNSHolding(s) in Company
28th May 20268:39 amRNSHolding(s) in Company
22nd May 20269:00 amRNSTender Offer Final Results
21st May 20269:04 amRNSHolding(s) in Company
19th May 20263:15 pmRNSPublication of Offering Circular
15th May 20264:00 pmRNSDirector/PDMR Shareholding
14th May 20262:58 pmRNSTender Offer - Maximum Acceptance
14th May 20269:18 amRNSTender Offer
6th May 202611:13 amRNSResult of AGM
6th May 20267:00 amRNS1st Quarter Results
30th Apr 20264:30 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSMotor Finance Redress Schemes Update
15th Apr 20264:30 pmRNSDirector/PDMR Shareholding
8th Apr 202611:00 amRNSDirector/PDMR Shareholding
31st Mar 20264:30 pmRNSTotal Voting Rights
18th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 20264:30 pmRNSNon-Executive Director Pension Transfer
4th Mar 20269:18 amRNSDirector/PDMR Shareholding
27th Feb 20264:34 pmRNSHolding(s) in Company
27th Feb 20264:30 pmRNSTotal Voting Rights
26th Feb 20267:00 amRNSPublication of Annual Report and AGM Notice
26th Feb 20267:00 amRNSResults for the year ended 31 December 2025
17th Feb 20264:30 pmRNSDirector/PDMR Shareholding
17th Feb 20263:54 pmRNSHolding(s) in Company
10th Feb 20263:33 pmRNSHolding(s) in Company
4th Feb 20264:32 pmRNSNotice of FY 2025 Results & Investor Presentations
30th Jan 20264:30 pmRNSTotal Voting Rights
30th Jan 20263:56 pmRNSHolding(s) in Company
23rd Jan 202612:40 pmRNSHolding(s) in Company
16th Jan 20262:55 pmRNSHolding(s) in Company
15th Jan 20264:30 pmRNSDirector/PDMR Shareholding
15th Jan 20263:02 pmRNSBlock listing Interim Review
8th Jan 20265:20 pmRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
16th Dec 20254:00 pmRNSDirector/PDMR Shareholding
9th Dec 20251:11 pmRNSHolding(s) in Company
8th Dec 20254:28 pmRNSHolding(s) in Company
5th Dec 20251:34 pmRNSHolding(s) in Company
28th Nov 20254:30 pmRNSTotal Voting Rights
24th Nov 20257:00 amRNSChange of Corporate Brokers
17th Nov 202512:44 pmRNSDirector/PDMR Shareholding
13th Nov 20253:09 pmRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNS3rd Quarter Trading Statement
31st Oct 20254:30 pmRNSTotal Voting Rights
16th Oct 20254:00 pmRNSDirector/PDMR Shareholding
13th Oct 20258:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.